Converge Bio
Computational platform using LLMs trained on biological and chemical data for drug discovery.
About
Converge Bio is a Generative AI Lab for the Life Sciences that accelerates drug development through AI-powered innovations in discovery, molecule design, and manufacturing. Their platform offers solutions for antibody design and screening, gene expression optimization, and target and biomarker discovery. Converge Bio serves pharmaceutical and biotech companies seeking to create tomorrow's therapies today. Teams look it up for Life Sciences, Generative AI, Large Language Models (LLMs).
Frequently asked
What does Converge Bio do?
Converge Bio is a Life Sciences company that offers Software. Teams look it up for Generative AI, Large Language Models (LLMs), Pharmaceutical. It is based in San Francisco, United States and was founded in 2023. Public records show about 51 people and $6M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Converge Bio raised?
Converge Bio has raised a total of $6M in funding. The most recent round on record is Seed.
Where is Converge Bio headquartered?
Converge Bio is headquartered in San Francisco, United States.
When was Converge Bio founded?
Converge Bio was founded in 2023.
What industry does Converge Bio operate in?
Converge Bio operates in Life Sciences, Generative AI, Large Language Models (LLMs), Pharmaceutical, Foundation Models.
How many employees does Converge Bio have?
Converge Bio has approximately 51 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.